Lakefront Biotherapeutics NV
Prices may be delayed up to 15 min. Not investment advice. News volume: articles about it in the 4Search index. Click a dot on the chart for the event and the news of that day.
Key statistics
Against its peers
Compare in full ›| GXE.F | BHVN | SLS | IOVA | 6YG.MU | 0A3M.IL | |
|---|---|---|---|---|---|---|
| Market cap | 1.98B | 1.87B | 2.78B | 3.19B | 1.20B | 22.20B |
| P/E (TTM) | 2.6 | — | — | — | — | 4.5 |
| Forward P/E | — | -8.1 | -55.8 | -54.1 | — | 4.5 |
| Price/book | 0.6 | -19.1 | 21.1 | 3.9 | 3.2 | 1.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +12.85% | +40.87% | +871.24% | +226.34% | −6.85% | −16.71% |
| Today | −2.39% | −9.23% | −8.08% | −5.61% | −5.56% | −2.17% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All GXE.F news ›Lakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology Meeting
Gamgertamig data from ongoing Phase 1b studies suggest potential to retain remission after B cell reconstitution, maintained in the absence of background therapy for autoimmune cytopenias, consistent with an “immune reset ” Lakefront to…
RBC Capital Keeps Their Buy Rating on Lakefront Biotherapeutics (LKFT)
RBC Capital analyst Brian Abrahams maintained a Buy rating on Lakefront Biotherapeutics yesterday and set a price target of $45.00. The company’s shares closed yesterday at $33.34. According to TipRanks, Abrahams is a 5-star analyst with…
Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT) and Merck & Company (MRK)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lakefront Biotherapeutics (LKFT) and Merck & Company (MRK). In a report issued on November 5, Brian Abrahams from RBC Capital maintained a Buy rating on…
Lakefront Biotherapeutics initiates new €50M share repurchase program
Lakefront Biotherapeutics (LKFT) launched a new share repurchase program of up to €50M after completing its initial €50M buyback on October 16, 2026 (which totaled ~1.99M ordinary shares). Effective November 16, 2026, through no later than…
Lakefront Biotherapeutics Reports Nine Months 2026 Financial Results and Provides Business Update
Gamgertamig poster accepted for presentation at the 2026 ASH1 Annual Meeting, featuring data from ongoing Phase 1b studies that suggest potential to retain remission after B cell reconstitution, maintained in the absence of background…
Lakefront Biotherapeutics GAAP EPS of €0.20, revenue of €26.1M
Earnings News Lakefront Biotherapeutics GAAP EPS of €0.20, revenue of €26.1M Nov 11, 2026, 4:03 PM ETLakefront Biotherapeutics NV (LKFT) StockBy: Harsh Shukla, SA News Editor Lakefront Biotherapeutics press release (LKFT): 9M GAAP EPS of…
LKFT: SEC Form 6-K filed by Lakefront Biotherapeutics
Lakefront furnished a Nov 2, 2026 press release as Exhibit 99.1; the 6-K body itself contains no financial or deal details. Plus members following LKFT got this by push and email at 16:35:57 ET - 2.1s after publication. Lakefront…
Lakefront Biotherapeutics Welcomes Dr. Mehdi Shahidi to its Board of Directors
Plus members following LKFT got this by push and email at 16:01:03 ET - 3.4s after publication. Written by Quantisnow AI from this release. Not financial advice. Dr. Mehdi Shahidi joins as a Non-Executive Independent Director, effective…
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Stock Now Rated “Hold” by Wall Street Brokerages
Posted by Defense World Staff on Oct 25th, 2026 View Our Latest Stock Analysis on Lakefront Biotherapeutics American Depositary Shares LKFT stock opened at $31.65 on Friday. The company has a market capitalization of $2.09 billion, a PE…
Critical Analysis: Protagonist Therapeutics (NASDAQ:PTGX) & Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT)
Posted by Defense World Staff on Oct 25th, 2026 Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT – Get Free Report) and Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) are both mid-cap healthcare companies, but…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- markets.businessinsider.com4
- quantisnow.com3
- defenseworld.net2
- seekingalpha.com2
- biospace.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.